| 2024-10 |
Long term outcomes of adjuvant radiation in early-stage breast cancer women with 65 years or older after breast-conserving surgery |
International Journal of Radiation Oncology Biology Physics. 2024 Oct;120(2, Suppl. ):E765. |
 |
| 2022-07 |
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors |
Annals of Oncology. 2022 Jul;33(Suppl. 6):S484. |
|
| 2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma |
Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550. |
|
| 2021-07 |
Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load |
Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S142. |
|
| 2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy |
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025. |
|
| 2020-02 |
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat |
Cancer Research. 2020 Feb;80(4, Suppl.):Meeting Abstract GS1-04. |
|
| 2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101. |
|
| 2018-01 |
The association between lifestyle factors and oral potentially malignant disorders in Taiwan |
Cancer Science. 2018 Jan;109(Suppl. 1):325. |
|
| 2017-07-31 |
The treatment patterns of non-metastatic prostate cancer in an Asian country |
International Journal of Urology. 2017 Jul 31;24(Suppl. S1):98. |
|
| 2017-05 |
Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 6590. |
|
| 2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification |
Journal of Hepatology. 2017;66(1, Suppl.):S259. |
|
| 2016-10-01 |
The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan |
International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):E301. |
|
| 2016-10-01 |
The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan |
International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):S15-S16. |
|
| 2016-10 |
The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study |
Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P. |
|
| 2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial |
Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99. |
|
| 2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024. |
|
| 2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection |
Journal of Hepatology. 2015 Apr;62, Suppl. 2:S563. |
|
| 2011-09 |
Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006 |
European Journal of Cancer. 2011 Sep;47(Suppl 1):S229-S230. |
|
| 2009-09 |
Performance of medical oncologists on end-of-life care for Taiwanese cancer decedents, 2001-2006 |
EJC Supplements. 2009 Sep;7(2):179. |
|
| 2009-09 |
Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors |
EJC Supplements. 2009 Sep;7(3):16. |
|
| 2007 |
A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients |
Journal of Hepatology. 2007;46(Suppl. 1):S297. |
|
| 2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma |
Head and Neck. 2006 Jan;28(1):74-80. |
|
| 2005-05-20 |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma |
Journal of Clinical Oncology. 2005 May;23(15):3568-3576. |
|
| 2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma |
International Journal of Cancer. 2002;Suppl. 13:336-337. |
|
| 1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC) |
European Journal of Cancer. 1999 Sep;35:S259. |
|
